Cargando…
PARP Inhibitor Decreases Akt Phosphorylation and Induces Centrosome Amplification and Chromosomal Aneuploidy in CHO-K1 Cells
Cancer cells are known to have chromosomal number abnormalities (aneuploidy), a hallmark of malignant tumors. Cancer cells also have an increased number of centrosomes (centrosome amplification). Paradoxically, cancer therapies, including γ-irradiation and some anticancer drugs, are carcinogenic and...
Autores principales: | Tanaka, Masakazu, Mushiake, Masatoshi, Takahashi, Jun, Sasaki, Yuka, Yamashita, Sachiko, Ida, Chieri, Masutani, Mitsuko, Miwa, Masanao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998298/ https://www.ncbi.nlm.nih.gov/pubmed/35408845 http://dx.doi.org/10.3390/ijms23073484 |
Ejemplares similares
-
RB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts
por: Iovino, Flora, et al.
Publicado: (2006) -
Depletion of the oncoprotein Bcl-3 induces centrosome amplification and aneuploidy in cancer cells
por: Zamora, Ruben, et al.
Publicado: (2010) -
ADP-Ribosylation as Post-Translational Modification of Proteins: Use of Inhibitors in Cancer Control
por: Poltronieri, Palmiro, et al.
Publicado: (2021) -
Physiological levels of poly(ADP-ribose) during the cell cycle regulate HeLa cell proliferation
por: Yamashita, Sachiko, et al.
Publicado: (2022) -
Centrosome amplification and aneuploidy driven by the HIV-1-induced Vpr•VprBP•Plk4 complex in CD4(+) T cells
por: Park, Jung-Eun, et al.
Publicado: (2023)